Breaking News Instant updates and real-time market news.

AKBA

Akebia

$7.91

0.44 (5.89%)

, KERX

Acquired by AKBA 12/18

$2.93

0.17 (6.16%)

17:19
11/15/18
11/15
17:19
11/15/18
17:19

Akebia and Keryx announce chairperson for combined company

Akebia Therapeutics (AKBA), and Keryx Biopharmaceuticals (KERX) announced that Adrian Adams will serve as the Chairperson of the Akebia Board of Directors, effective upon completion of the proposed merger of Akebia and Keryx.

AKBA

Akebia

$7.91

0.44 (5.89%)

KERX

Acquired by AKBA 12/18

$2.93

0.17 (6.16%)

  • 27

    Nov

  • 11

    Dec

  • 11

    Dec

AKBA Akebia
$7.91

0.44 (5.89%)

08/23/18
HCWC
08/23/18
NO CHANGE
HCWC
Keryx, Akebia merger remains on track, says H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert believes the merger between Keryx Biopharmaceuticals (KERX) and Akebia Therapeutics (AKBA) remains on track. According to the Federal Trade Commission website, the status of the merger application now shows "granted," Kolbert tells investors in a research note. The analyst says that while he did not expect FTC clearance to be an issue, "it's good to see it granted." He keeps a Buy rating on Keryx with a $9 price target.
09/07/18
MSCO
09/07/18
INITIATION
Target $9
MSCO
Equal Weight
Akebia resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst David Lebowitz resumed coverage of Akebia (AKBA) with an Equal Weight rating and $9 price target, stating that value is primarily driven by the potential of vadadustat as a treatment for anemia associated with chronic kidney disease. Vadadustat is a year behind FibroGen's (FGEN) competing HIF-inhibitor roxadustat and that lead could be an advantage if the data for the two drugs is not sufficiently differentiated, said Lebowitz.
10/22/18
MZHO
10/22/18
NO CHANGE
Target $17
MZHO
Buy
Akebia 'significantly undervalued' ahead of catalysts, says Mizuho
Mizuho analyst Difei Yang views Akebia Therapeutics as "significantly undervalued" ahead of catalysts expected in 2019 including data readouts from vadadustat and launch metrics from Auryxia. The stock is one to pay attention to in 2019 following poor performance in 2018 "despite making progress in multiple pivotal trials," Yang tells investors in a research note. She lowered her price target for the shares to $17 from $21 and keeps a Buy rating on Akebia.
11/12/18
11/12/18
DOWNGRADE

Market Perform
Raymond James downgrades Keryx to Market Perform ahead of Akebia deal closing
As previously reported, Raymond James analyst Reni Benjamin downgraded Keryx (KERX) to Market Perform from Outperform as he sees shares trading in-line with the market until the merger with Akebia (AKBA) is complete. The potential merger with Akebia is likely to go through by year-end, Benjamin contends. The merged company is likely to become "a fully-integrated renal powerhouse," the analyst added.
KERX Acquired by AKBA 12/18
$2.93

0.17 (6.16%)

07/12/18
PIPR
07/12/18
NO CHANGE
Target $22
PIPR
Overweight
Piper incrementally positive on Akebia shares, ups target to $22
Piper Jaffray analyst Christopher Raymond is incrementally positive on shares of Akebia Therapeutics after new nephrologist survey data indicated that Auryxia "has not just turned a corner, but is really on quite a roll, both in terms of the drug's perception and its market share dynamics." With the stock down 4% since before last month's merger announcement with Keryx (KERX), Raymond sees a "significant opportunity" to own Akebia before the drug's near-term share gains and the "real potential of a nephrology powerhouse with both Auryxia and vadadustat, become more apparent." He raised his price target for the shares to $22 from $20 and keeps an Overweight rating on the name.
11/12/18
RAJA
11/12/18
DOWNGRADE
RAJA
Market Perform
Keryx downgraded to Market Perform from Outperform at Raymond James

TODAY'S FREE FLY STORIES

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:40
04/26/19
04/26
07:40
04/26/19
07:40
Hot Stocks
American Airlines reports Q1 PRASM up 0.6% »

Passenger demand drove a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

07:40
04/26/19
04/26
07:40
04/26/19
07:40
General news
Oil Action: WTI crude »

Oil Action: WTI crude has…

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

, S

Sprint

$5.61

-0.01 (-0.18%)

07:39
04/26/19
04/26
07:39
04/26/19
07:39
Recommendations
T-Mobile, Sprint analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

S

Sprint

$5.61

-0.01 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

07:38
04/26/19
04/26
07:38
04/26/19
07:38
Conference/Events
The National Press Club to host a luncheon meeting »

Panera Bread Founder…

PRO

Pros Holdings

$45.06

-0.25 (-0.55%)

07:37
04/26/19
04/26
07:37
04/26/19
07:37
Recommendations
Pros Holdings analyst commentary  »

ProsHoldings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

PFPT

Proofpoint

$131.35

3.56 (2.79%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Recommendations
Proofpoint analyst commentary at KeyBanc »

Proofpoint price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

CELG

Celgene

$93.93

0.82 (0.88%)

, XLRN

Acceleron

$41.19

0.62 (1.53%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Hot Stocks
Celgene, Acceleron announces submission of luspatercept MAA to EMA »

Celgene Corporation…

CELG

Celgene

$93.93

0.82 (0.88%)

XLRN

Acceleron

$41.19

0.62 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 04

    May

  • 07

    May

  • 18

    May

  • 31

    May

  • 27

    Jun

  • 03

    Sep

ACB

Aurora Cannabis

$9.07

-0.045 (-0.49%)

07:36
04/26/19
04/26
07:36
04/26/19
07:36
Hot Stocks
Aurora Cannabis makes $10M equity investment in EnWave »

To further cement the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$318.30

-7.02 (-2.16%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Recommendations
Arista Networks analyst commentary at Nomura Instinet »

Arista Networks price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 10

    Jun

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Earnings
American Airlines lowers FY19 adj. EPS view to $4.00-$6.00 from $5.50-$7.50 

Consensus $5.63.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

, INTC

Intel

$57.59

-1.13 (-1.92%)

07:35
04/26/19
04/26
07:35
04/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

FB

Facebook

$193.23

10.59 (5.80%)

INTC

Intel

$57.59

-1.13 (-1.92%)

MRVL

Marvell

$25.42

-0.03 (-0.12%)

APC

Anadarko

$71.76

0.35 (0.49%)

OXY

Occidental Petroleum

$61.81

-0.19 (-0.31%)

ZNGA

Zynga

$5.47

-0.115 (-2.06%)

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

CARA

Cara Therapeutics

$19.39

0.335 (1.76%)

RSG

Republic Services

$79.46

0.16 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 01

    May

  • 05

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 14

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 25

    Jul

  • 13

    Nov

07:34
04/26/19
04/26
07:34
04/26/19
07:34
Conference/Events
FDA Anti-Microbial Drugs Advisory Committee to hold a meeting »

The Committee discusses…

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

, QRVO

Qorvo

$77.33

0.09 (0.12%)

07:34
04/26/19
04/26
07:34
04/26/19
07:34
Recommendations
Broadcom, Qorvo analyst commentary  »

Broadcom price target…

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

QRVO

Qorvo

$77.33

0.09 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:33
04/26/19
04/26
07:33
04/26/19
07:33
Earnings
American Airlines reports Q1 adj. EPS 52c, consensus 51c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

QRVO

Qorvo

$77.33

0.09 (0.12%)

, AVGO

Broadcom

$311.99

-2.11 (-0.67%)

07:32
04/26/19
04/26
07:32
04/26/19
07:32
Downgrade
Qorvo, Broadcom rating change  »

Qorvo downgraded to…

QRVO

Qorvo

$77.33

0.09 (0.12%)

AVGO

Broadcom

$311.99

-2.11 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

IMAX

Imax

$25.05

0.02 (0.08%)

07:31
04/26/19
04/26
07:31
04/26/19
07:31
Earnings
Imax reports Q1 adjusted EPS 18c, consensus 18c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 15

    May

  • 05

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Amazon.com analyst commentary at Barclays »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

AJG

Arthur J. Gallagher

$82.75

0.68 (0.83%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Arthur J. Gallagher analyst commentary at SunTrust »

Arthur J. Gallagher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 20

    May

SFUN

Fang Holdings

$1.62

0.08 (5.19%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Earnings
Breaking Earnings news story on Fang Holdings »

Fang Holdings sees FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SAVE

Spirit Airlines

$52.91

-5.39 (-9.25%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Recommendations
Spirit Airlines analyst commentary at Stephens »

Spirit Airlines issues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 12

    Jun

  • 13

    Nov

SWN

Southwestern Energy

$4.03

-0.13 (-3.13%)

, YPF

YPF

$13.70

-0.29 (-2.07%)

07:30
04/26/19
04/26
07:30
04/26/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

SWN

Southwestern Energy

$4.03

-0.13 (-3.13%)

YPF

YPF

$13.70

-0.29 (-2.07%)

WAB

Wabtec

$71.41

-5.16 (-6.74%)

MAS

Masco

$37.50

-2.48 (-6.20%)

ODFL

Old Dominion

$152.25

-6.74 (-4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 10

    May

  • 10

    May

  • 15

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 05

    Jun

  • 13

    Nov

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:29
04/26/19
04/26
07:29
04/26/19
07:29
Recommendations
Amazon.com analyst commentary at Wedbush »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

SFUN

Fang Holdings

$1.62

0.08 (5.19%)

07:28
04/26/19
04/26
07:28
04/26/19
07:28
Earnings
Fang Holdings reports Q4 non-GAAP EPS 2c vs. 5c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

APD

Air Products

$199.63

0.13 (0.07%)

07:27
04/26/19
04/26
07:27
04/26/19
07:27
Recommendations
Air Products analyst commentary  »

Air Products price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$105.09

1 (0.96%)

07:26
04/26/19
04/26
07:26
04/26/19
07:26
Recommendations
Tractor Supply analyst commentary at Wedbush »

Tractor Supply price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 25

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.